Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2009-02-24
2011-10-04
Shafer, Shulamith H (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100, C435S070210, C435S070300, C435S326000, C435S344100, C435S320100, C435S358000, C536S023530, C536S023500, C536S023100
Reexamination Certificate
active
08030026
ABSTRACT:
The subject invention relates to antibodies to troponin I as well as methods of use thereof. In particular, such antibodies may be used to detect Troponin I in a patient and may also be used in the diagnosis of, for example, a myocardial infarction or acute coronary syndrome.
REFERENCES:
patent: 4526938 (1985-07-01), Churchill
patent: 4816397 (1989-03-01), Boss
patent: 4816567 (1989-03-01), Cabilly
patent: 4880078 (1989-11-01), Inoue
patent: 5006309 (1991-04-01), Khalil
patent: 5063081 (1991-11-01), Cozzette
patent: 5089424 (1992-02-01), Khalil
patent: 5128326 (1992-07-01), Balazs
patent: 5223409 (1993-06-01), Ladner
patent: 5225539 (1993-07-01), Winter
patent: 5290540 (1994-03-01), Prince
patent: 5530101 (1996-06-01), Queen
patent: 5565332 (1996-10-01), Hoogenboom
patent: 5565352 (1996-10-01), Hochstrasser
patent: 5585089 (1996-12-01), Queen
patent: 5624821 (1997-04-01), Winter
patent: 5648260 (1997-07-01), Winter
patent: 5679377 (1997-10-01), Berstein
patent: 5693762 (1997-12-01), Queen
patent: 5705330 (1998-01-01), Shah
patent: 5714350 (1998-02-01), Co
patent: 5714352 (1998-02-01), Jakobovits
patent: 5723323 (1998-03-01), Kauffman
patent: 5763192 (1998-06-01), Kauffman
patent: 5766886 (1998-06-01), Studnicka
patent: 5807715 (1998-09-01), Morrison
patent: 5814476 (1998-09-01), Kauffman
patent: 5817483 (1998-10-01), Kauffman
patent: 5824514 (1998-10-01), Kauffman
patent: 5855913 (1999-01-01), Hanes
patent: 5874064 (1999-02-01), Edwards
patent: 5912015 (1999-06-01), Bernstein
patent: 5912120 (1999-06-01), Goldstein
patent: 5916597 (1999-06-01), Lee
patent: 5934272 (1999-08-01), Lloyd
patent: 5976862 (1999-11-01), Kauffman
patent: 5985309 (1999-11-01), Edwards
patent: 5985320 (1999-11-01), Edwards
patent: 5989463 (1999-11-01), Tracy
patent: 6019968 (2000-02-01), Platz
patent: 6180370 (2001-01-01), Queen
patent: 6194222 (2001-02-01), Buechler et al.
patent: 6204023 (2001-03-01), Robinson
patent: 6350861 (2002-02-01), Co
patent: 6699658 (2004-03-01), Wittrup
patent: 7285418 (2007-10-01), Katrukha
patent: 7371383 (2008-05-01), Reed et al.
patent: 2002/0137134 (2002-09-01), Gerngross
patent: 2003/0170881 (2003-09-01), Davis
patent: 2003/0186374 (2003-10-01), Hufton
patent: 2004/0018577 (2004-01-01), Campbell
patent: 2004/0018590 (2004-01-01), Gerngross
patent: 2005/0054078 (2005-03-01), Miller
patent: 2006/0018897 (2006-01-01), Lee
patent: 2006/0160164 (2006-07-01), Miller
patent: 86631 (1983-08-01), None
patent: 229246 (1987-07-01), None
patent: 239400 (1987-09-01), None
patent: 519596 (1992-12-01), None
patent: 592106 (1993-07-01), None
patent: 239400 (1994-03-01), None
patent: 592106 (1994-04-01), None
patent: 1176195 (2002-01-01), None
patent: 519596 (2005-02-01), None
patent: 2014302 (2009-01-01), None
patent: 2779526 (1999-12-01), None
patent: 8901334 (1990-05-01), None
patent: 9101134 (1992-01-01), None
patent: 9201755 (1993-04-01), None
patent: 9005144 (1990-05-01), None
patent: 9014424 (1990-11-01), None
patent: 9014430 (1990-11-01), None
patent: 9014443 (1990-11-01), None
patent: 9105548 (1991-05-01), None
patent: 9105939 (1991-05-01), None
patent: 9109630 (1991-07-01), None
patent: 9109967 (1991-07-01), None
patent: 9117271 (1991-11-01), None
patent: 9201047 (1992-01-01), None
patent: 9209690 (1992-06-01), None
patent: 9215679 (1992-09-01), None
patent: 9218619 (1992-10-01), None
patent: 9219244 (1992-11-01), None
patent: 9220791 (1992-11-01), None
patent: 9301288 (1993-01-01), None
patent: 9401234 (1994-01-01), None
patent: 9618978 (1996-06-01), None
patent: 9620698 (1996-07-01), None
patent: 9729131 (1997-08-01), None
patent: 9732572 (1997-09-01), None
patent: 9744013 (1997-11-01), None
patent: 9816280 (1998-04-01), None
patent: 9831346 (1998-07-01), None
patent: 9915154 (1999-04-01), None
patent: 9920253 (1999-04-01), None
patent: 9954342 (1999-10-01), None
patent: 9966903 (1999-12-01), None
patent: 0183525 (2001-11-01), None
patent: 02072636 (2002-09-01), None
patent: 03016466 (2003-02-01), None
patent: 03035835 (2003-05-01), None
patent: WO2005000901 (2005-01-01), None
patent: 2005100584 (2005-10-01), None
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295, under the heading “Fv Structure and Diversity in Three Dimensions”.
Rudikoff et al Proc. Natl. Acad. Sci.USA, 79(6):1979-1983, Mar. 1982.
Colman P. M. Research in Immunology, 145:33-36, 1994.
Filatov V. L., et al., “Epitope Mapping of Anti-Troponin I Monoclonal Antibodies, XP000941112,” Biochemistry and Molecular Biology International, 36039, 45 (6), Academic Press, London, GB, 1179-1187.
PCT International Search Report and Written Opinion of International Application No. PCT/US2010/024979 mailed on May 6, 2010, 21 pages.
Peronnet, et al., “Isoelectric point determination of cardiac troponin I forms present 1n plasma from patients with myocardial Infarction, NL LNKDD0I: 10.1016/J.CCA.2006.10.006, XP005805375,” Clinica Chimica Acta, 39066, 377 (1-2), Elsevier BV, Amsterdam, 243-247.
Rama D., et al., “Epitope Localization of Monoclonal Antibodies Used in Human Troponin I Immunoenzymometric Assay, XP009033257,” Hybridoma, 35431, 16 (2), Liebert, New York, NY, US, 153-157.
Altshchul, et al., Nucleic Acids Research, vol. 25 pp. 3389-3402 (1997).
Azzazy, H., et al., Clin. Biochem., vol. 35 pp. 425-445 (2002).
Barbas, et al., PNAS, vol. 88 pp. 7978-7982 (1991).
Bird, et al., Science, vol. 242 pp. 423-426 (1988).
Bodar, et al., Clinical Chemistry, vol. 38 pp. 2203-2214 (1992).
Boder, et al., Nature Biotechnology, vol. 15 pp. 553-557 (Jun. 1997).
Buchwald, et al., Surgery, vol. 88 p. 507 (1980).
Carter, et al., Proc. Natl. Acad. Sci., vol. 89 p. 4285, USA (1992).
Chothia, et al., J. Mol. Biol., vol. 196 pp. 901-917 (1987).
Chothia, et al., J. Mol. Biol., vol. 227 p. 799 (1992).
Chothia, et al., Nature, vol. 342 pp. 877-883 (1989).
Clackson, et al., Nature, vol. 352 pp. 624-628 (1991).
Cleek, et al., “Biodegradable Polymeric Carriers for a bFGF Antibody for Cardiovascular Application,” Pro. Int'l. Symp. Control. Rel. Bioact. Mater., vol. 24 pp. 853-854 (1997).
Co, M.S., et al., Mol. Immunol., vol. 30 pp. 1361-1367 (1993).
Controlled Drug Bioavailability, Drug Product Design and Performance, Smolen and Ball (eds), Wiley, New York (1984).
Cummins, et al., Am. Heart Journal, vol. 113 pp. 1333-1344 (1987).
During, et al., Ann. Neurol., vol. 25 p. 351 (1989).
Foote, et al., J. Mol. Biol., vol. 224 pp. 487-499 (1992).
Fuchs, et al., Bio/Technology, vol. 9 pp. 1370-1372 (1991).
Garrad, et al., Bio/Technology, vol. 9 pp. 1373-1377 (1991).
Gavilondo, J.V., et al., BioTechniques, vol. 29 pp. 128-145 (2000).
Giege, R., et al., Crystallization of Nucleic Acids and Proteins , a Practical Approach, 2ndEdition, pp. 20 1-16, Oxford University Press, New York, New York (1999).
Gillies, et al., J. Immunol. Methods, vol. 125 pp. 191-202 (1989).
Goodson, et al., Medical Applications of Controlled Release, supra, vol. 2 pp. 115-138 (1984).
Gram, et al., PNAS, vol. 89 pp. 3576-3580 (1992).
Griffiths, et al., EMBO J., vol. 12 pp. 725-734 (1993).
Hay, et al., Hum. Antibod. Hybridomas, vol. 3 pp. 81-85 (1992).
Hawkins, et al., J. Mol. Biol., vol. 226 pp. 889-896 (1992).
Higgins, et al., CABIOS, 5L151-5L153 (1989).
Holliger, P., et al., Proc. Natl. Acad. Sci., vol. 90 pp. 6444-6448, USA (1993).
Hoogenboom, et al., Nuc. Acid Res., vol. 19 pp. 4133-4137 (1991).
Hoogenboom, H.R., et al., TIB Tech., vol. 15 pp. 62-70 (1997).
Hoogenboom, H., et al., Immunology Today, vol. 21 pp. 371-378 (2000).
Howard, et al., J. Neurosurg., vol. 71 p. 105 (1989).
Huse, et al., Science, vol. 246 pp. 1275-1281 (1989).
Huston, et al., Proc. Natl. Acad. Sci., vol. 85 pp. 5879-5883, USA (1988).
Jefferis, R., et al., Biotechnol. Prog., vol. 21 pp. 11-16 (2005.
Johnsson, B., et al., J. Mol. Recognit., vol. 8 pp. 125-131 (1995).
Johnsson, B., et al., Anal. Biochem., vol. 198 pp. 268-277 (1991).
Jones, et al., Nature, vol. 321 pp. 522 (1986).
Jönsson, U., et al., Biotechniques, vol. 11 pp. 620-627 (1991).
Jonsson, U., et al. Ann. Biol. Clin. 51: 19-26 (1993).
Kabat, et al., Ann. NY Acad. Sci.,
Brophy Susan E.
Huang Dagang
Tu Bailin
Tyner Joan D.
Tyner, legal representative Lowell J.
Abbott Laboratories
Becker Cheryl L.
Shafer Shulamith H
LandOfFree
Antibodies to troponin I and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to troponin I and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to troponin I and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4283296